Fredun Pharmaceuticals Ltd — Important, 29-12-2025: Company Update

The company's board has approved the preferential allotment of 6,44,360 equity shares at ₹1,250 each, raising **₹80.55 Cr**. Additionally, 5,51,600 convertible warrants were allotted at ₹1,250 each, with the company receiving **₹17.24 Cr** (25% of issue price) upfront. These warrants can be converted into equity shares within 18 months, potentially raising another **₹51.71 Cr**. This strategic move injects capital into the company, supporting its operations and future growth plans, and brings in 62 new investors.